BFK-24806-65516
3 vaccinations
1 coded response
34 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 066 / CT
- Registered
- 2021-04-26
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-24
Dose 1 — Pfizer-BioNTech
-
2021-04-26
Registered in v-safe
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-08
-
2021-05-15
Dose 2 — Pfizer-BioNTech
- 2021-05-15
-
2021-05-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Muscle or body achesAdult check-in
-
2021-05-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-20
- 2021-05-21
- 2021-05-22
- 2021-05-29
- 2021-06-05
- 2021-06-12
- 2021-06-19
- 2021-06-28
- 2021-08-14
- 2021-11-13
-
2021-12-06
Dose 3 — Pfizer-BioNTech
-
2021-12-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-12-10
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-12-12
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-12-13
- 2021-12-20
-
2021-12-27
Survey response — day 21, dose 3MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-01-03
- 2022-01-10
- 2022-01-19
- 2022-03-07
- 2022-06-06
- 2022-12-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-24 | Pfizer-BioNTech | |
| 2 | 2021-05-15 | Pfizer-BioNTech | |
| 3 | 2021-12-06 | Pfizer-BioNTech | No |
Free text
Release 10 — day 21, dose 3
Symptoms: Cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release